Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA-matching.

Oltolini C, Greco R, Galli L, Clerici D, Lorentino F, Xue E, Stanghellini MTL, Giglio F, Uhr L, Ripa M, Scarpellini P, Bernardi M, Corti C, Peccatori J, Castagna A, Ciceri F.

Biol Blood Marrow Transplant. 2020 Jan 28. pii: S1083-8791(20)30045-8. doi: 10.1016/j.bbmt.2020.01.013. [Epub ahead of print]

PMID:
32004700
2.

Robust information for effective municipal solid waste policies: Identifying behaviour of waste generation across spatial levels of organization.

Torrente-Velásquez JM, Chifari R, Ripa M, Giampietro M.

Waste Manag. 2019 Dec 27;103:208-217. doi: 10.1016/j.wasman.2019.12.032. [Epub ahead of print]

PMID:
31887693
3.

Landfill reactions to society actions: The case of local and global air pollutants of Cerro Patacón in Panama.

Torrente-Velásquez JM, Giampietro M, Ripa M, Chifari R.

Sci Total Environ. 2020 Mar 1;706:135988. doi: 10.1016/j.scitotenv.2019.135988. Epub 2019 Dec 7.

PMID:
31841844
4.

Ceftobiprole for the treatment of infective endocarditis: A case series.

Tascini C, Attanasio V, Ripa M, Carozza A, Pallotto C, Bernardo M, Francisci D, Oltolini C, Palmiero G, Scarpellini P.

J Glob Antimicrob Resist. 2019 Jul 24;20:56-59. doi: 10.1016/j.jgar.2019.07.020. [Epub ahead of print]

5.

Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens.

Gianotti N, Muccini C, Galli L, Poli A, Spagnuolo V, Andolina A, Galizzi N, Ripa M, Messina E, Piatti PM, Lazzarin A, Castagna A.

J Med Virol. 2019 Nov;91(11):1937-1943. doi: 10.1002/jmv.25541. Epub 2019 Jul 16.

PMID:
31286527
6.

Day-Length Is Involved in Flooding Tolerance Response in Wild Type and Variant Genotypes of Rootstock Prunus cerasifera L.

Iacona C, Pistelli L, Cirilli M, Gatti L, Mancinelli R, Ripa MN, Muleo R.

Front Plant Sci. 2019 May 3;10:546. doi: 10.3389/fpls.2019.00546. eCollection 2019.

7.

Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study.

Jensen JS, Weeke PE, Bang LE, Høfsten DE, Ripa MS, Schjerning AM, Theilade JE, Køber LV, Gislason GH, Pallisgaard J.

BMJ Open. 2019 Apr 1;9(4):e022702. doi: 10.1136/bmjopen-2018-022702.

8.

LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples.

Ferrari D, Ripa M, Premaschi S, Banfi G, Castagna A, Locatelli M.

J Pharm Biomed Anal. 2019 May 30;169:11-18. doi: 10.1016/j.jpba.2019.02.037. Epub 2019 Feb 21.

PMID:
30826487
9.

Comparison of FTD® respiratory pathogens 33 and a singleplex CDC assay for the detection of respiratory viruses: A study from Cameroon.

Kenmoe S, Tcharnenwa C, Monamele GC, Kengne CN, Ripa MN, Whitaker B, Alroy KA, Balajee SA, Njouom R.

Diagn Microbiol Infect Dis. 2019 Jul;94(3):236-242. doi: 10.1016/j.diagmicrobio.2019.01.007. Epub 2019 Jan 16.

PMID:
30738690
10.

Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.

Ripa M, Morata L, Rodríguez-Núñez O, Cardozo C, Puerta-Alcalde P, Hernández-Meneses M, Ambrosioni J, Linares L, Bodro M, Valcárcel A, Casals C, Guerrero-León MLA, Almela M, Garcia-Vidal C, Del Río A, Marco F, Mensa J, Martínez JA, Soriano A.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00892-18. doi: 10.1128/AAC.00892-18. Print 2018 Nov.

11.

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.

Oltolini C, Ripa M, Andolina A, Brioschi E, Cilla M, Petrella G, Gregorc V, Castiglioni B, Tassan Din C, Scarpellini P.

Mycopathologia. 2019 Feb;184(1):181-185. doi: 10.1007/s11046-018-0291-4. Epub 2018 Aug 13. Review.

PMID:
30101407
12.

Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa.

Rodríguez-Núñez O, Ripa M, Morata L, de la Calle C, Cardozo C, Fehér C, Pellicé M, Valcárcel A, Puerta-Alcalde P, Marco F, García-Vidal C, Del Río A, Soriano A, Martínez-Martínez JA.

J Glob Antimicrob Resist. 2018 Dec;15:136-139. doi: 10.1016/j.jgar.2018.07.010. Epub 2018 Jul 20.

PMID:
30036695
13.

Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen.

Gianotti N, Galli L, Galizzi N, Ripa M, Andolina A, Nozza S, Spagnuolo V, Poli A, Lazzarin A, Castagna A.

Int J Antimicrob Agents. 2018 Oct;52(4):492-499. doi: 10.1016/j.ijantimicag.2018.07.001. Epub 2018 Sep 13.

PMID:
30009958
14.

Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging.

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y.

J Electrocardiol. 2018 Jul - Aug;51(4):563-568. doi: 10.1016/j.jelectrocard.2018.03.016. Epub 2018 Apr 4.

PMID:
29996989
15.

The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging.

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y.

Ann Noninvasive Electrocardiol. 2018 Nov;23(6):e12580. doi: 10.1111/anec.12580. Epub 2018 Jul 4.

PMID:
29971868
16.

Eosinophils from Physiology to Disease: A Comprehensive Review.

Ramirez GA, Yacoub MR, Ripa M, Mannina D, Cariddi A, Saporiti N, Ciceri F, Castagna A, Colombo G, Dagna L.

Biomed Res Int. 2018 Jan 28;2018:9095275. doi: 10.1155/2018/9095275. eCollection 2018. Review.

17.

Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI.

Jia X, Heiberg E, Ripa MS, Engblom H, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y.

Scand Cardiovasc J. 2018 Aug;52(4):189-195. doi: 10.1080/14017431.2018.1458145. Epub 2018 Mar 29.

PMID:
29595340
18.

Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis-authors' response.

Ripa M, Rodríguez-Nuñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F, Morata L, De La Calle C, Del Río A, Garcia-Vidal C, Ortega MDM, Guerrero-León MLA, Fehér C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA.

J Antimicrob Chemother. 2018 Jun 1;73(6):1732-1733. doi: 10.1093/jac/dky063. No abstract available.

PMID:
29506238
19.

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.

Gianotti N, Poli A, Nozza S, Galli L, Galizzi N, Ripa M, Merli M, Carbone A, Spagnuolo V, Lazzarin A, Castagna A.

BMC Infect Dis. 2017 Nov 16;17(1):723. doi: 10.1186/s12879-017-2831-9.

20.

Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis.

Ripa M, Rodríguez-Núñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F, Morata L, De La Calle C, Del Rio A, Garcia-Vidal C, Ortega MDM, Guerrero-León MLA, Feher C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA.

J Antimicrob Chemother. 2017 Dec 1;72(12):3443-3452. doi: 10.1093/jac/dkx315.

PMID:
28961801
21.

Assessment of stormwater runoff management practices and BMPs under soil sealing: A study case in a peri-urban watershed of the metropolitan area of Rome (Italy).

Recanatesi F, Petroselli A, Ripa MN, Leone A.

J Environ Manage. 2017 Oct 1;201:6-18. doi: 10.1016/j.jenvman.2017.06.024.

PMID:
28633079
22.

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response.

Nozza S, Poli A, Ripa M, Galli L, Chiappetta S, Spagnuolo V, Rovelli C, Lazzarin A, Castagna A, Tambussi G.

J Antimicrob Chemother. 2017 May 1;72(5):1549-1550. doi: 10.1093/jac/dkx073. No abstract available.

PMID:
28333303
23.

Immunosenescence and hurdles in the clinical management of older HIV-patients.

Ripa M, Chiappetta S, Tambussi G.

Virulence. 2017 Jul 4;8(5):508-528. doi: 10.1080/21505594.2017.1292197. Epub 2017 Feb 21. Review.

24.

Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up.

Ripa M, Pogliaghi M, Chiappetta S, Nozza S, Soria A, Coppalini G, Rovelli C, Tambussi G.

J Clin Virol. 2016 Dec;85:86-89. doi: 10.1016/j.jcv.2016.10.016. Epub 2016 Oct 31.

PMID:
27865174
25.

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.

Nozza S, Poli A, Ripa M, Galli L, Chiappetta S, Spagnuolo V, Rovelli C, Lazzarin A, Castagna A, Tambussi G.

J Antimicrob Chemother. 2017 Feb;72(2):632-633. doi: 10.1093/jac/dkw439. Epub 2016 Oct 17. No abstract available.

PMID:
27798217
26.

48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study.

Nozza S, Pignataro AR, Galli L, Svicher V, Alteri C, Boeri E, Ripa M, Castagna A, Sampaolo M, Clementi M, Perno CF, Lazzarin A.

New Microbiol. 2016 Jul;39(3):192-196.

27.

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.

Gianotti N, Galli L, Poli A, Salpietro S, Nozza S, Carbone A, Merli M, Ripa M, Lazzarin A, Castagna A.

Medicine (Baltimore). 2016 May;95(22):e3780. doi: 10.1097/MD.0000000000003780.

28.

Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.

Chiappetta S, Ripa M, Galli L, Razzari C, Longo V, Galli A, Faioni EM, Nozza S, Lazzarin A, Tambussi G.

J Antimicrob Chemother. 2016 Jun;71(6):1627-31. doi: 10.1093/jac/dkw010. Epub 2016 Feb 16.

PMID:
26888911
29.

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.

Pogliaghi M, Ripa M, Pensieroso S, Tolazzi M, Chiappetta S, Nozza S, Lazzarin A, Tambussi G, Scarlatti G.

PLoS One. 2015 Oct 16;10(10):e0140435. doi: 10.1371/journal.pone.0140435. eCollection 2015.

30.

Life Cycle Assessment of Mixed Municipal Solid Waste: Multi-input versus multi-output perspective.

Fiorentino G, Ripa M, Protano G, Hornsby C, Ulgiati S.

Waste Manag. 2015 Dec;46:599-611. doi: 10.1016/j.wasman.2015.07.048.

PMID:
26257056
31.

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.

Ripa M, Pogliaghi M, Chiappetta S, Galli L, Pensieroso S, Cavarelli M, Scarlatti G, De Biasi S, Cossarizza A, De Battista D, Malnati M, Lazzarin A, Nozza S, Tambussi G.

Clin Microbiol Infect. 2015 Sep;21(9):876.e1-4. doi: 10.1016/j.cmi.2015.05.007. Epub 2015 May 14.

32.

Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study.

Nozza S, Galli L, Antinori A, Chiappetta S, Mazzotta F, Zaccarelli M, Ottou S, De Battista D, Pogliaghi M, Di Pietro M, Malnati M, Ripa M, Bonora S, Lazzarin A; VEMAN Study Group.

Clin Microbiol Infect. 2015 May;21(5):510.e1-9. doi: 10.1016/j.cmi.2014.12.006. Epub 2014 Dec 11.

33.

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.

Ceresola ER, Nozza S, Sampaolo M, Pignataro AR, Saita D, Ferrarese R, Ripa M, Deng W, Mullins JI, Boeri E, Tambussi G, Toniolo A, Lazzarin A, Clementi M, Canducci F.

J Antimicrob Chemother. 2015 May;70(5):1391-5. doi: 10.1093/jac/dku573. Epub 2015 Jan 20.

34.

Anisometropia in children with neurofibromatosis type 1 and unilateral optic glioma.

Schmidt EJ, Ripa MD, Davitt BV, Cruz OA.

J AAPOS. 2014 Dec;18(6):623. doi: 10.1016/j.jaapos.2014.07.161. Epub 2014 Nov 1. No abstract available.

PMID:
25438951
35.

Linking phosphorus export and hydrologic modeling: a case study in Central Italy.

Petroselli A, Leone A, Ripa MN, Recanatesi F.

Environ Monit Assess. 2014 Nov;186(11):7849-61. doi: 10.1007/s10661-014-3972-6. Epub 2014 Aug 7.

PMID:
25098900
36.

Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine.

Nozza S, Galli L, Bigoloni A, Gianotti N, Spagnuolo V, Carbone A, Chiappetta S, Ripa M, Tambussi G, Lazzarin A, Castagna A.

New Microbiol. 2014 Apr;37(2):145-51. Epub 2014 Apr 1.

37.

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection.

Nozza S, Bigoloni A, Calcagno A, Galli L, Pignataro AR, D'Avolio A, Carbone A, Ripa M, Bonora S, Lazzarin A, Castagna A.

J Antimicrob Chemother. 2014 May;69(5):1436-9. doi: 10.1093/jac/dkt530. Epub 2014 Jan 23. No abstract available.

PMID:
24458511
38.

Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infection.

Nozza S, Pignataro AR, Galli L, Ripa M, Boeri E, Chiappetta S, Galli A, Canducci F, Sampaolo M, Clementi M, Lazzarin A, Tambussi G.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e27-9. doi: 10.1097/QAI.0b013e3182a03ed2. No abstract available.

PMID:
24419069
39.

Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient.

Ripa M, Chiappetta S, Nozza S.

Int J STD AIDS. 2013 Dec;24(12):980-2. doi: 10.1177/0956462413491080. Epub 2013 Jul 11.

PMID:
23970624
40.

Land use, climate and transport of nutrients: evidence emerging from the Lake Vico Case Study [corrected].

Recanatesi F, Ripa MN, Leone A, Perini L, Salvati L.

Environ Manage. 2013 Aug;52(2):503-13. doi: 10.1007/s00267-013-0060-6. Epub 2013 May 17. Erratum in: Environ Manage. 2013 Sep;52(3):758. Luigi, Perini [corrected to Perini, Luigi]; Luca, Salvati [corrected to Salvati, Luca].

PMID:
23680855
41.

The ECG as decision support in STEMI.

Ripa MS.

Dan Med J. 2012 Mar;59(3):B4413.

PMID:
22381096
42.

Corneal ulceration in a dog following exposure to the defensive spray of a walkingstick insect (Anisomorpha spp.).

Brutlag AG, Hovda LR, Della Ripa MA.

J Vet Emerg Crit Care (San Antonio). 2011 Aug;21(4):382-6. doi: 10.1111/j.1476-4431.2011.00654.x. Epub 2011 Jun 30.

PMID:
21827597
43.

Canine bronchoesophageal fistulas: case report and literature review.

Della Ripa MA, Gaschen F, Gaschen L, Cho DY.

Compend Contin Educ Vet. 2010 Apr;32(4):E1. Review.

PMID:
20949418
44.

Agricultural nitrate monitoring in a lake basin in Central Italy: a further step ahead towards an integrated nutrient management aimed at controlling water pollution.

Garnier M, Recanatesi F, Ripa MN, Leone A.

Environ Monit Assess. 2010 Nov;170(1-4):273-86. doi: 10.1007/s10661-009-1231-z. Epub 2009 Nov 13.

PMID:
19911291
45.

Vulnerability and risk evaluation of agricultural nitrogen pollution for Hungary's main aquifer using DRASTIC and GLEAMS models.

Leone A, Ripa MN, Uricchio V, Deák J, Vargay Z.

J Environ Manage. 2009 Jul;90(10):2969-78. Epub 2007 Dec 3.

PMID:
18054423
46.

Agricultural land use and best management practices to control nonpoint water pollution.

Ripa MN, Leone A, Garnier M, Lo Porto A.

Environ Manage. 2006 Aug;38(2):253-66.

PMID:
16779698
47.

[Telemedicine in the transmission of prehospitalisation ECGs of patients with suspected acute myocardial infarction].

Sillesen M, Ripa MS, Strange S, Nielsen SL, Jørgensen E, Lippert FK, Clemmensen PM.

Ugeskr Laeger. 2006 Mar 13;168(11):1133-6. Danish.

PMID:
16545220

Supplemental Content

Support Center